. 2016 Mar 1;62(10):1235–1241. doi: 10.1093/cid/ciw112

Table 4.

Detection of Interferon Gamma in Blood Samples From Patients With Early Lyme Disease Collected Pretreatment or 2 Months Posttreatment With Doxycycline

Subject	Levels (IU/mL) of IFN-γ in Blood Samples Collected^a
Subject	Pretreatment	2 mo Posttreatment
1	1.16^b	0
2	0	0.06
3	5.03^b	0
4	0	0
5	0	0
6	3.86^b	2.61^b
7	1.82^b	0.16
8	0.45^b	0.02
9	1.69^b	1.59^b
10	0.78^b	0.46^b
11	0.49^b	0.12
12	0.29	0
13	0.33^b	0
14	0	0
15	2.58^b	0
16	2.02^b	0.11
17	0	0
18	10.61^b	1.12^b
19	0.42^b	0
20	0	0.12
21	0	0
22	2.29^b	NT
23	4.99^b	0.21
24	0.75^b	0.27
25	0.43^b	NT
26	0.47^b	0.20
27	0.82^b	0.30
28	0.66^b	0.05
29	0.30	0

Abbreviations: IFN-γ, interferon gamma; NT, not tested.

^a Values displayed are the IFN-γ value obtained from peptide stimulation of whole blood samples minus nil tube reactivity (Supplementary Table 2).

^b Results are ≥3 standard deviations above the mean value (≥0.33 IU/mL) of normal (n = 187) and anaplasmosis (n = 5) sera.